Vertex Pharma’s takeover of Alpine Immune is a strategic fit: analysts

Published on 11 Apr 2024 on Market Watch

Alpine Immune’s lead candidate is being evaluated as a potential treatment for IgA Nephropathy, or...

Read the rest of the article

Start tracking your investments with Statfolio

Artificial intelligence has been a hot area of investment for so long now that it's virtually...

Investing.com 8 Nov 2024

Novartis AG (SIX:NOVN) (NYSE: NVS), a global healthcare company, has reported a solid third-quart...

Investing.com 31 Oct 2024

On Tuesday, Novartis AG (NYSE:NVS) reported third-quarter sales of $12.823 billion, up 9% (+10% o...

Benzinga · via AOL 31 Oct 2024

*Stock Advisor returns as of October 28, 2024 Vasant Narasimhan -- Chief Executive... Kirsch on t...

The Motley Fool · via AOL 29 Oct 2024

, opens new tab raised its 2024 earnings guidance for the third time on Tuesday, buoyed by wider ...

Reuters 29 Oct 2024

On Tuesday, Novartis AG (NYSE:NVS) reported third-quarter sales of $12.823 billion, up 9% (+10% o...

Benzinga · via Yahoo Finance 29 Oct 2024

Monte Rosa Therapeutics Inc (NASDAQ:GLUE) stock is trading higher on Monday after the company...

Benzinga · via AOL 28 Oct 2024

We recently published a list of 10 Wonderful Stocks to Buy Now at a Fair Price. In this article, ...

Insider Monkey · via Yahoo Finance 6 Oct 2024

We recently compiled a list of the 10 Best Cancer Stocks To Buy Now. In this article, we are goin...

Insider Monkey · via Yahoo Finance 24 Aug 2024

We recently compiled a list of the Top 10 Stocks on Jim Cramer’s Radar. In this article, we are...

Insider Monkey · via Yahoo Finance 24 Aug 2024